Rosetta Genomics Ltd (NASDAQ:ROSG)

0.36
Delayed Data
As of 12:35pm ET
 +0.0107 / +3.06%
Today’s Change
0.23
Today|||52-Week Range
2.82
-35.14%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Quarter 2
2017
Revenue and IncomeNet Revenues2.4M2.2M2.0M870.0K
 
 
 
 
 
Cost of Goods Sold2.0M1.8M2.0M569.0K
 
 
 
 
 
 
Operating ExpensesGross Income423.0K410.0K17.0K301.0K
 
 
 
 
 
General Expenses3.8M4.4M4.3M1.7M
 
 
 
 
 
Research And Development618.0K879.0K818.0K476.0K
 
 
 
 
 
Total Operating Expenses5.8M6.1M6.3M2.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.4M-3.9M-4.3M-1.4M
 
 
 
 
 
Interest Expense On Debt--16.0K563.0K--
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.4M-4.0M-4.9M-1.1M
 
 
 
 
 
Income Taxes-6.0K-10.0K-56.0K0.00
 
 
 
 
Discontinued Operations0.000.000.00-929.0K
 
 
Net Income-3.4M-4.0M-4.8M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.7M1.7M1.8M2.5M
 
 
 
 
 
Shares To Calculate EPS Diluted1.7M1.7M1.8M2.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.92-$2.28---$0.81
 
 
 
 
EPS Diluted-$1.92-$2.28-$2.76-$0.81